IP Library Granted Patent US 9,802,886
Granted Patent B2
US 9,802,886 · App. 15/348,093 · Granted Oct 31, 2017

Process for making lysine-glutamic acid dipeptide derivatives

Inventor: Kurt Puentener (Basel, CH)
Assignee: Hoffmann-La Roche Inc.
C07C269/06C07C271/22C07C2603/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,802,886
App. No.
15/348,093
Granted
Oct 31, 2017
Kind
B2
Abstract

The invention relates to compounds of the formula and to a process for making same and to the use of the products in the solid phase peptide synthesis. The compounds of formula I are versatile peptide intermediates for the solid phase peptide synthesis (SPPS) of peptide drugs which comprise a Glu-fatty alkyl side chain building block attached to a Lys-part of the peptide chain.

Claims (27)

1. A process for the preparation of compounds of formula I,

and enantiomers and salts thereof, wherein:

R 1 is hydrogen or an ester protecting group;

R 2 is hydrogen;

R 3 is hydrogen or an amino protecting group and

R 4 is C 12-20 -alkyl;

the process comprising:

a) coupling the glutamic acid derivative of formula II

or a salt thereof with a lysine derivative of formula III

wherein R 2′ is an ester protecting group, or a salt thereof to form a compound of the formula Ic;

and

b) removing the ester protecting group R 2′ to provide the compound of formula I.

2. The process of claim 1 , wherein the ester protecting group is selected from C 1-4 -alkyl, optionally substituted with phenyl, C 2-4 -alkenyl, piperidinyl or dimethylaminoboranyl.

3. The process of claim 1 , wherein R 1 is hydrogen or C 1-4 -alkyl.

4. The process of claim 1 , wherein R 1 is C 1-4 -alkyl.

5. The process of claim 1 , wherein R 1 is hydrogen.

6. The process of claim 1 , wherein R 3 is 9H-fluoren-9-ylmethoxycarbonyl.

7. The process of claim 1 , wherein R 1 is t-butyl.

8. The process of claim 1 , wherein R 4 is C 14-16 -alkyl.

9. The process of claim 1 , wherein R 4 is C 15 -alkyl.

10. The process of claim 1 , wherein R 4 is pentadecyl.

11. The process of claim 1 , wherein R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is C 15 -alkyl.

12. The process of claim 1 , wherein R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is pentadecyl.

13. The process of claim 1 , wherein the compound of formula I is a compound of formula Ia

14. The process of claim 1 , wherein the compound of formula I is a compound of formula Ib

15. The process of claim 1 , wherein the coupling of the glutamic acid derivative of formula II with the lysine derivative of formula III is carried out by solid phase synthesis.

16. The process of claim 1 , wherein the coupling of the glutamic acid derivative of formula II with the lysine derivative of formula III is carried out by FMOC solid phase synthesis.

Priority Claims (1)
EP 12168119 · May 15, 2012 · regional
Continuity (3)
Division 14539126 · Nov 12, 2014
Continuation PCTEP2013059759 · May 13, 2013
Related Publication 20170057912A1 · Mar 2, 2017